The slip
PARKINSON RECEIPTno. 0917
17 Oct 2026, 09:40 UTCdopamine neurons, braak
predictionMPRIP in dopamine neurons tracks Braak Lewy-body stage
registerede94eae04a63432dc
discovery-0.67 p=0.049 n=9
replication+0.32 p=0.407 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.67 p 0.049; held-out +0.32 p 0.407)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE9727583523c3b491585ef188…
follows f2f72ace762d…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0917: MPRIP in dopamine neurons, braak
- power
- full sample -0.30 (p 0.225, n 18), 95% CI -0.67 to +0.19. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.30 (p 0.221, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.45 (p 0.063, n 18). could be the mix.
- skeptic
- leave-one-out range -0.40 to -0.21, sign flips 0; without severely affected donors -0.30 (p 0.225, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.60 (p 0.0080, n 18) vs -0.30 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MPRIP in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up MPRIP · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.30 p 0.286 (needs p < 0.0014)